MDS to sell Central Labs to Chiltern owner
MDS Pharma Services’ Central Labs division is to be acquired by Czura Thornton, a private investment group that owns Chiltern, for approximately $8m (€5.4m) as part of the CRO’s repositioning.
Archives for October 11, 2009
USP targets counterfeits in Cambodia
The USAID and USP have launched a campaign to tackle counterfeits in Cambodia and Greater Mekong Subregion, using a film to educate the population of the dangers of fakes and need to use legitimate pharmacies.
NextPharma adds clinical trial services at San Diego facility
NextPharma Technologies has added clinical trial services to its US offering to meet what product development services MD Sean Marett described as growing demand for single source outsourcing solutions.
Heptares calls on Sygnature for discovery chemistry
Sygnature Chemical Services will provide synthetic chemistry services for Heptares Therapeutics GPCR drug development programme under a deal signed last week.
Postmarketing outsourcing worth over $1bn; Quintiles SVP
Quintiles and Cerner are combining their “unique sets of experience and expertise” to improve the efficiency of late phase research, the market for which exceeds $1bn (€677m), according to a SVP at the CRO.
Millipore rolls out CellReady 3L benchtop bioreactor
Millipore has expanded its Mobius process technology range with the new CellReady 3L bench-top bioreactor.